Transparency

LANSING - Pharmaceutical companies would have to report to the state and the public annually how they set the prices of their prescription drugs under an eight-bill transparency package approved by the Michigan House Health Policy Committee. But the committee rejected, in party-line fashion, several attempts by Democrats to put more teeth into the bills,